---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-115372"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2024-11-07T23:59:59+00:00"
generated_at: "2026-05-30T03:20:13.097227+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# ClearPoint Neuro enters $50M ATM equity offering with Stifel

## Summary
- ATM agreement with Stifel allows sale of up to $50M in common stock from time to time.
- Agent commission of 3.0% of gross sales proceeds; shares sold via Nasdaq Capital Market.
- Prospectus supplement filed Nov 7, 2024; registration statement effective since Nov 20, 2023.
- Company not obligated to sell any shares; may suspend or terminate offering at any time.

## SEC filing metadata
- accession: 0001104659-24-115372
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2024-11-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000110465924115372/0001104659-24-115372-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000110465924115372/tm2427351d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-115372
- JSON: https://secwatch.observer/filing/0001104659-24-115372.json
- Plain text: https://secwatch.observer/filing/0001104659-24-115372.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.